Hyaluronic Acid in Hepatitis C

In Hepatitis C, published studies report higher levels of Hyaluronic Acid than in healthy controls. The source does not tie this marker to a specific symptom cluster, so it is best read as a biological signal rather than a symptom predictor. The finding is drawn from Voumvouraki et al. 2011; it describes group-level differences, not a threshold that classifies an individual.

↑ ElevatedMusculoskeletal

Summary

Direction in Hepatitis C↑ Elevated — higher than in the comparison group
CategoryMusculoskeletal
Compared againsthealthy controls
SourceVoumvouraki et al. 2011 — doi:10.1016/j.ejim.2010.10.002
Condition atlasHepatitis C Biomarker Atlas

Other conditions where Hyaluronic Acid is reported

See the cross-condition hub: Hyaluronic Acid across conditions.

Related Musculoskeletal markers in Hepatitis C

Full list: Hepatitis C Biomarker Atlas.

Frequently asked questions

Is Hyaluronic Acid high or low in Hepatitis C?

Elevated. Studies summarised in the OSMF atlas report higher Hyaluronic Acid in Hepatitis C than in healthy controls. Source: Voumvouraki et al. 2011.

Which test measures Hyaluronic Acid?

The atlas record does not list a standardised clinical test code (LOINC) for Hyaluronic Acid, which usually means it was measured with research assays or study-specific protocols rather than a routine clinical panel. Check the cited source for the exact method.

Is one abnormal Hyaluronic Acid result diagnostic of Hepatitis C?

No. No single biomarker is diagnostic of Hepatitis C. Hyaluronic Acid findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.

Is Hyaluronic Acid specific to Hepatitis C?

No. The same marker is also reported in Osteoarthritis in this atlas, so it reflects shared biology (for example inflammation or vascular stress) rather than a condition-specific signature.

Cite this page

Open Source Medicine Foundation. (2026). Hyaluronic Acid in Hepatitis C: direction, evidence and what it means. OSMF Research Tracker. Retrieved October 8, 2026, from https://research.opensourcemed.info/biomarkers/hepatitis-c/hyaluronic-acid.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-10-08 · Page generated from hepatitis-c.json · Browse: Hepatitis C atlas · Biomarker Index · All marker pages

Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.